affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →
Is CertaPeptides legit?
CertaPeptides is operating and surfaces credible public signals (composite 78/100), but we have not placed a first-hand test order yet — this is a public-data audit. EU-based (Romania) research-peptide supplier that does the thing our rubric rewards — real third-party Janoshik COAs hosted on Janoshik's own public portal, with verifiable report IDs, real compound names, and an honest two-tier split between "independently tested" lots and "supplier batch specification" lots. The main caveats are scope and age — only about a third of the catalog has an independent report (the rest is a supplier ≥98% class spec, not a per-lot measurement), and the operation is new despite a "founded 2024" claim. Public-data preview; first-hand audit pending. The signal table below shows what we verified and what is still open.
Signal table
What works, what does not
- +Publishes genuine third-party Janoshik Analytical COAs (HPLC + mass spec, several with heavy-metals panels) linked directly to Janoshik's public verify portal — buyers can confirm report IDs the vendor cannot edit
- +Honest two-tier labeling — "Janoshik Verified" vs "Supplier Batch Specification" — and explicitly states the supplier spec describes a class standard, not a measurement of the specific lot. Unusually transparent framing for the niche
- +Uses real compound names and CAS numbers (Semaglutide, Tirzepatide, Retatrutide) rather than proprietary relabels, so cross-vendor per-mg comparison is straightforward
- +Named EU legal entity (CERTALAB S.R.L., Bucharest, Romania) and a named founder, with a registered company number and phone — more corporate transparency than most grey-market vendors
- +Intra-EU shipping from Romania to 33 countries with tracking, which sidesteps the customs-seizure risk that hits US/UK-to-EU parcels
- +Competitive EUR pricing, especially on the GLP-1 cluster (semaglutide from EUR 19.49, tirzepatide from EUR 30.99), with a published affiliate/referral program
- +Runs a security page warning buyers about a typosquat domain — a sign of an operator paying attention to brand-impersonation risk
- −Only ~20 of ~58 catalogue entries carry an independent Janoshik report; the remaining ~38 ship on a supplier "≥98% class spec" that, by the vendor's own admission, is not a measurement of the lot you receive
- −New operation — the Romanian entity registration (J2026...) and the WordPress media library both date to 2026, which sits awkwardly against the site's "Founded 2024" / "2024 lab partnerships" timeline
- −Payment is SEPA and Paysera only (no card or crypto) — fine for EU bank-transfer buyers, a hard stop for everyone else
- −No first-hand order placed by us, and no independent community track record retrieved yet — purity claims rest on the vendor's own published reports until we test a vial ourselves
- −Vendor self-submitted for inclusion; this profile is preview-data only, first-hand audit pending
What we mean by "legit"
We do not use "legit" as a single yes-or-no signal. A vendor is legit when four things hold: identifiable corporate operator, third-party or independently-mirrored COAs, shipping and payment infrastructure that consistently delivers, and a complaint history that surfaces real issues rather than vanishes them. Our composite score is the weighted average of those four — shipping, pricing, support, COA quality — and you can read the full rubric at /methodology.
For CertaPeptides the audit is "public-data tier" — we aggregate vendor disclosures, third-party COA mirrors, operating-history evidence, and complaint patterns. A first-hand test order is still pending and the page will be upgraded when that lands.
Verdict
EU-based (Romania) research-peptide supplier that does the thing our rubric rewards — real third-party Janoshik COAs hosted on Janoshik's own public portal, with verifiable report IDs, real compound names, and an honest two-tier split between "independently tested" lots and "supplier batch specification" lots. The main caveats are scope and age — only about a third of the catalog has an independent report (the rest is a supplier ≥98% class spec, not a per-lot measurement), and the operation is new despite a "founded 2024" claim. Public-data preview; first-hand audit pending.
Other audited vendors
Sources
- CertaPeptides catalog — vendor
- CertaPeptides COA Vault (Janoshik reports + supplier specs) — vendor
- About CertaPeptides (CERTALAB S.R.L., Romania) — vendor
- CertaPeptides — Retatrutide 15mg Janoshik report #172228 (99.344%) — lab
- CertaPeptides — Tirzepatide 10mg Janoshik report #172231 (99.596%) — lab
- Janoshik 7,164-tests purity analysis — vialaudit